These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16162110)

  • 21. [Fulminant hepatitis-like veno-occlusive disease of the liver after allogeneic bone marrow transplantation in acute lymphoblastic leukemia].
    Naito H; Arioka H; Kobayashi R; Ishikawa Y
    Rinsho Ketsueki; 1993 May; 34(5):656-61. PubMed ID: 8315837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
    Carreras E; Rosiñol L; Terol MJ; Alegre A; de Arriba F; García-Laraña J; Bello JL; García R; León A; Martínez R; Peñarrubia MJ; Poderós C; Ribas P; Ribera JM; San Miguel J; Bladé J; Lahuerta JJ;
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1448-54. PubMed ID: 18022574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
    Kim I; Keam B; Lee KH; Kim JH; Oh SY; Ra EK; Yoon SS; Park SS; Kim CS; Park S; Hong YC; Kim BK
    Clin Transplant; 2007; 21(2):207-13. PubMed ID: 17425746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation.
    Ringdén O; Remberger M; Lehmann S; Hentschke P; Mattsson J; Klaesson S; Aschan J
    Bone Marrow Transplant; 2000 May; 25(9):993-6. PubMed ID: 10800069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.
    Ho VT; Revta C; Richardson PG
    Bone Marrow Transplant; 2008 Feb; 41(3):229-37. PubMed ID: 17994121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases.
    Miyakoshi S; Kami M; Tanimoto T; Yamaguchi T; Narimatsu H; Kusumi E; Matsumura T; Takagi S; Kato D; Kishi Y; Murashige N; Yuji K; Uchida N; Masuoka K; Wake A; Taniguchi S
    Transplantation; 2007 Aug; 84(3):316-22. PubMed ID: 17700155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unrelated cord blood transplantation after myeloablative conditioning in patients with acute leukemia aged between 50 and 55 years.
    Konuma T; Ooi J; Takahashi S; Tomonari A; Uchiyama M; Fukuno K; Tsukada N; Iseki T; Tojo A; Asano S
    Bone Marrow Transplant; 2006 Apr; 37(8):803-4. PubMed ID: 16518422
    [No Abstract]   [Full Text] [Related]  

  • 29. Safe administration of oral BU twice daily during conditioning for stem cell transplantation in a paediatric population: a comparative study between the standard 4-dose and a 2-dose regimen.
    Mellgren K; Nilsson C; Fasth A; Abrahamsson J; Winiarski J; Ringdén O; Hassan M
    Bone Marrow Transplant; 2008 Apr; 41(7):621-5. PubMed ID: 18084338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelium as 'novel' target of graft-versus-host disease.
    Tichelli A; Gratwohl A
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):139-48. PubMed ID: 18503982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation.
    Sebagh M; Azoulay D; Roche B; Hoti E; Karam V; Teicher E; Bonhomme-Faivre L; Saliba F; Duclos-Vallée JC; Samuel D
    Liver Transpl; 2011 Jul; 17(7):798-808. PubMed ID: 21351239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatic veno-occlusive disease after hemopoetic stem cell transplantation].
    Da W; Zhong J; Liu Y
    Zhonghua Nei Ke Za Zhi; 1995 Jun; 34(6):374-7. PubMed ID: 8582182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-transplant hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.
    Ho V; Momtaz P; Didas C; Wadleigh M; Richardson P
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E3. PubMed ID: 16029969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
    Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic veno-occlusive disease with severe capillary leakage after peripheral stem cell transplantation: treatment with recombinant plasminogen activator and C1-esterase inhibitor concentrate.
    Heying R; Nürnberger W; Spiekerkötter U; Göbel U
    Bone Marrow Transplant; 1998 May; 21(9):947-9. PubMed ID: 9613790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double treatment of severe hepatic veno-occlusive disease after allogeneic peripheral blood progenitor cell transplantation with recombinant tissue plasminogen activator.
    Söhngen D; Bauser U; Boogen C; Aul C; Frieling T; Germing U; Schneider P; Kobbe G; Heyll A
    Thromb Haemost; 1997 Oct; 78(4):1299-300. PubMed ID: 9365005
    [No Abstract]   [Full Text] [Related]  

  • 37. Micafungin does not influence the concentration of tacrolimus in patients after allogeneic hematopoietic stem cell transplantation.
    Fukuoka N; Imataki O; Ohnishi H; Kitanaka A; Kubota Y; Ishida T; Tanaka T
    Transplant Proc; 2010 Sep; 42(7):2725-30. PubMed ID: 20832577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation.
    Cheuk DK; Wang P; Lee TL; Chiang AK; Ha SY; Lau YL; Chan GC
    Bone Marrow Transplant; 2007 Nov; 40(10):935-44. PubMed ID: 17768390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver dysfunction in the early post-bone marrow transplant period.
    Storek J
    Cas Lek Cesk; 1996 May; 135(10):295-8. PubMed ID: 8697490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic screening and complications of hematopoietic stem cell transplantation: has the time come?
    Kallianpur AR
    Bone Marrow Transplant; 2005 Jan; 35(1):1-16. PubMed ID: 15489868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.